“…In terms of the study population, three studies included the general adult population (Chaves & Oyama, 2008;Cupertino, Cartujano-Barrera, Perales et al, 2019;Cupertino, Cartujano-Barrera, Ramírez et al, 2019), two studies focused on hospitalized adults (Cruvinel et al, 2019;de Azevedo et al, 2010), one study focused on adults with chronic conditions (Cupertino et al, 2020), and another study focused on young adults (Blitchtein-Winicki et al, 2017) Cruvinel et al, 2019;Cupertino, Cartujano-Barrera, Perales et al, 2019;Cupertino, Cartujano-Barrera, Ramírez et al, 2019;Cupertino et al, 2020), and Day 30 (one study; Blitchtein-Winicki et al, 2017) abstinence rates. Six studies used intention-to-treat analysis (Blitchtein-Winicki et al, 2017;Chaves & Oyama, 2008;Cruvinel et al, 2019;Cupertino, Cartujano-Barrera, Perales et al, 2019;Cupertino, Cartujano-Barrera, Ramírez et al, 2019;Cupertino et al, 2020) and one study used complete case analysis ( de Azevedo et al, 2010). Cessation rates varied from 9.4% self-reported 7day point prevalence abstinence at Week 12 (Cupertino et al, 2020) to 55.5% self-reported 30-day point prevalence abstinence at Day 30 (Blitchtein-Winicki et al, 2017).…”